The weighted-average grant-date fair value for option awards granted during the years ended December 31, 2016, 2015 and
2014 was $98.7, $108.28 and $94.01 per share. The weighted-average grant-date fair value for ESPP granted during the years ended
December 31, 2016, 2015 and 2014 was $51.31, $58.77 and $74.07 per share. The fair value of RSUs is measured on the grant date
based on the closing fair market value of our common stock.
2014 Performance-based Stock Options Grants
In 2014, to create incentives for continued long term success beyond the Model S program and to closely align executive pay
with our stockholders’ interests in the achievement of significant milestones by our Company, the Compensation Committee of our
Board of Directors granted stock options to certain employees to purchase an aggregate 1,073,000 shares of our common stock. Each
such grant consists of four vesting tranches with a vesting schedule based entirely on the attainment of future performance milestones,
assuming continued employment and service to us through each vesting date.
0 l/4th of the shares subject to the options are scheduled to vest upon completion of the first Model X Production Vehicle;
0 l/4th of the shares subject to the options are scheduled to vest upon achieving aggregate vehicle production of 100,000
vehicles in a trailing 12-month period;
c l/4th of the shares subject to the options are scheduled to vest upon completion of the first Model 3 Production Vehicle;
and
o l/4th of the shares subject to the options are scheduled to vest upon achievement of annualized gross margin of greater
than 30.0% in any three years
As of December 31, 2016, the following performance milestone was achieved and approved by our Board of Directors.
0 Completion of the first Model X Production Vehicle
As of December 31, 2016, the following performance milestone was considered probable of achievement.
0 Completion of the first Model 3 Production Vehicle; and
o Achieving aggregate vehicle production of 100,000 vehicles in a trailing 12-month period
We begin recording stock-based compensation expense as each milestone becomes probable. As of December 31, 2016, we had
unrecognized compensation expense of $17.5 million for those performance milestones that were not considered probable of
achievement. For the years ended December 31, 2016, 2015 and 2014, we recorded stock-based compensation expense of $25.3
million, $10.4 million and $10.7 million related to this grant.
2012 CEO Grant
In August 2012, our Board of Directors granted 5,274,901 stock options to our CEO (the “2012 CEO Grant”). The 2012 CEO
Grant consists of ten vesting tranches with a vesting schedule based entirely on the attainment of both performance conditions and
market conditions, assuming continued employment and service to us through each vesting date.
Each of the ten vesting tranches requires a combination of one of the ten pre-determined performance milestones and an
incremental increase in our market capitalization of $4.0 billion, as compared to the initial market capitalization of $3.2 billion
measured at the time of the 2012 CEO Grant.
As of December 3 l, 2016, the market conditions for seven vesting tranches and the following five performance milestones were
achieved and approved by our Board of Directors:
0 Successful completion of the Model X Alpha Prototype;
0 Successful completion of the Model X Beta Prototype;
0 Completion of the first Model X Production Vehicle;
0 Aggregate vehicle production of 100,000 vehicles; and
0 Successful completion of the Model 3 Alpha Prototype.
As of December 31, 2016, the following performance milestones were considered probable of achievement:
0 Successful completion of the Model 3 Beta Prototype;
0 Completion of the first Model 3 Production Vehicle;
92